SCIENTIFIC publications

/cun/en/investigacion/publicaciones-cientificas/areaMain/02
  • MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer

    Garcia-Velloso MJ (1), Ribelles MJ (2), Rodriguez M (2), Fernandez-Montero A (3), Sancho L (2), Prieto E (2), Santisteban M (4), Rodriguez-Spiteri N (5), Idoate MA (6), Martinez-Regueira F (5), Elizalde A (7), Pina LJ (7).

    (1) Department of Nuclear Medicine, Clinica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Spain.
    (2) Department of Nuclear Medicine, Clinica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Spain.
    (3) Department of Occupational Medicine, Clinica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Spain.
    (4) Department of Oncology, Clinica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Spain.
    (5) Department of Surgery, Clinica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Spain.
    (6) Department of Pathology, Clinica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Spain.
    (7) Department of Radiology, Clinica Universidad de Navarra, Avenida Pio XII 36, 31008, Pamplona, Spain.

    European Radiology 01 AUGUST 2017

  • Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis

    Castañón E (1,2), Rolfo C (3), Viñal D (4), López I (5), Fusco JP (6), Santisteban M (7), Martin P (8), Zubiri L (9), Echeveste JI (10), Gil-Bazo I (11,12).
    (1) Department of Oncology, Clínica Universidad de Navarra, Avenida Pío XII, 36, 31008, Pamplona, Spain.
    (2) Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), Pamplona, Spain.
    (3) Department of Oncology, Antwerp University Hospital UZA, Edegem, Belgium. Christian.
    (4) Department of Oncology, Clínica Universidad de Navarra, Avenida Pío XII, 36, 31008, Pamplona, Spain. 
    (5) Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), Pamplona, Spain.
    (6) Department of Oncology, Clínica Universidad de Navarra, Avenida Pío XII, 36, 31008, Pamplona, Spain.
    (7) Department of Oncology, Clínica Universidad de Navarra, Avenida Pío XII, 36, 31008, Pamplona, Spain.
    (8) Department of Oncology, Clínica Universidad de Navarra, Avenida Pío XII, 36, 31008, Pamplona, Spain. 
    (9) Department of Oncology, Clínica Universidad de Navarra, Avenida Pío XII, 36, 31008, Pamplona, Spain. 
    (10) Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.
    (11) Department of Oncology, Clínica Universidad de Navarra, Avenida Pío XII, 36, 31008, Pamplona, Spain. 
    (12) Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), Pamplona, Spain.  

    Journal of Translational Medicine 07 AUGUST 2015

  • Time to loading and locoregional control in perioperative high-dose-rate brachytherapy: The tumor bed effect revisited

    Martínez-Monge R(1), Valtueña G(2), Santisteban M(3), Cambeiro M(2), Arbea L(2), Ramos LI(2), Olarte A(2), San-Julián M(4), Alcalde J(5), Naval-Gías L(6), Jurado M(7).

    (1) Department of Radiation Oncology, Clínica Universidad de Navarra, University of Navarre, Pamplona, Navarre, Spain; Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarre, Spain. Electronic address: rmartinezm@unav.es.
    (2) Department of Radiation Oncology, Clínica Universidad de Navarra, University of Navarre, Pamplona, Navarre, Spain; Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarre, Spain.
    (3) Department of Medical Oncology, Clínica Universidad de Navarra, University of Navarre, Pamplona, Navarre, Spain; Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarre, Spain.
    (4) Department of Orthopedic Surgery, Clínica Universidad de Navarra, University of Navarre, Pamplona, Navarre, Spain; Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarre, Spain.
    (5) Department of Otolaryngology, Clínica Universidad de Navarra, University of Navarre, Pamplona, Navarre, Spain; Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarre, Spain.
    (6) Department of Oral Surgery, Clínica Universidad de Navarra, University of Navarre, Pamplona, Navarre, Spain; Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarre, Spain.
    (7) Department of Gynecology, Clínica Universidad de Navarra, University of Navarre, Pamplona, Navarre, Spain; Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Navarre, Spain.

    Brachytherapy 01 JULY 2015

  • 37th Annual San Antonio Breast Cancer Symposium. Resumen de las aportaciones translacionales y clínicas más relevantes

    M. Santisteban, S. de la Cruz, J. Espinós, J.M. Aramendía, O. Fernández Hidalgo
    Departamento de Oncología Médica de la Clínica Universidad de Navarra

    Revista de Senología y Patología Mamaria 01 MARCH 2015

  • Epidermal Growth Factor Receptor targeting in non-small cell lung cancer: revisiting different strategies against the same target

    Castañón E, Martín P, Rolfo C, Fusco JP, Ceniceros L, Legaspi J, Santisteban M, Gil-Bazo I.
    Department of Oncology, Clínica Universidad de Navarra, 31008 Pamplona, Spain

    Current Drug Targets 01 JUNE 2014

you mayBE INTERESTED

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra